SARS-CoV-2 with Influenza B Coinfection in a Patient with Sickle Cell HbSC Presenting with Painful Crisis: A Case Report.

Autor:	Ali EA; Internal Medicine, Interfaith Medical Center, Brooklyn, USA., Fadul A; Internal Medicine, Hamad Medical Corporation, Doha, QAT., Subahi EA; Internal Medicine, Hamad Medical Corporation, Doha, QAT., Ahmed M; Internal Medicine, Interfaith Medical Center, Brooklyn, USA., Elamin A; Internal Medicine, Interfaith Medical Center, Brooklyn, USA., Thwin M; Internal Medicine, Interfaith Medical Center, Brooklyn, USA., Guillaume E; Hematology and Medical Oncology, Interfaith Medical Center, Brooklyn, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2024 Mar 13; Vol. 16 (3), pp. e56102. Date of Electronic Publication: 2024 Mar 13 (Print Publication: 2024).
DOI:	10.7759/cureus.56102
Abstrakt:	Sickle cell disease is a hereditary red blood cell disorder characterized by hemolytic anemia, particularly in association with stress. As they grow, most children with sickle cell anemia undergo auto-splenectomy, making them vulnerable to serious infections. Patients with sickle cell disease infected with the SARS-CoV-2 virus are reported to have an increased risk for hospitalization, thrombosis, and other complications compared to non-sickle cell patients. Influenza infection in patients with sickle cell is associated with increased morbidity. Patients with sickle cell HbSC are reported to have a milder form of the disease than HbSS. Coinfection with SARS-CoV-2 and influenza B is rarely reported in patients with hematologic diseases, including sickle cell hemoglobinopathy. We are reporting an unusual case of a patient with sickle cell HbSC with co-infection of SARS-CoV-2 and influenza B with a favorable outcome. Competing Interests: The authors have declared that no competing interests exist. (Copyright © 2024, Ali et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu